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MenaINV mediates synergistic cross-talk between 
signaling pathways driving chemotaxis and 
haptotaxis
ABSTRACT Directed cell migration, a key process in metastasis, arises from the combined 
influence of multiple processes, including chemotaxis—the directional movement of cells to 
soluble cues—and haptotaxis—the migration of cells on gradients of substrate-bound factors. 
However, it is unclear how chemotactic and haptotactic pathways integrate with each other 
to drive overall cell behavior. MenaINV has been implicated in metastasis by driving chemo-
taxis via dysregulation of phosphatase PTP1B and more recently in haptotaxis via interaction 
with integrin α5β1. Here we find that MenaINV-driven haptotaxis on fibronectin (FN) gradients 
requires intact signaling between α5β1 integrin and the epidermal growth factor receptor 
(EGFR), which is influenced by PTP1B. Furthermore, we show that MenaINV-driven haptotaxis 
and ECM reorganization both require the Rab-coupling protein RCP, which mediates α5β1 and 
EGFR recycling. Finally, MenaINV promotes synergistic migratory response to combined EGF 
and FN in vitro and in vivo, leading to hyperinvasive phenotypes. Together our data demon-
strate that MenaINV is a shared component of multiple prometastatic pathways that amplifies 
their combined effects, promoting synergistic cross-talk between RTKs and integrins.
INTRODUCTION
Directed cell motility is required for many physiological processes 
and can be driven by various cues. One example is the process of 
metastasis—the dissemination of cells from a primary tumor to sec-
ondary sites in the body—which is responsible for 90% of deaths 
associated with cancer. Directional cues induce the local invasion of 
tumor cells into adjacent tissue and vasculature, ultimately leading 
to metastatic dissemination. Chemotaxis—the directional move-
ment of cells attracted to a source of soluble cues that diffuse pas-
sively onto the cells—has been studied extensively in many systems 
(Bear and Haugh, 2014). In particular, epidermal growth factor (EGF) 
secreted by tumor-associated macrophages acts as a powerful che-
motactic attractant for nearby breast tumor cells (Wyckoff et al., 
2004). Extracellular matrix (ECM) proteins also drive directed migra-
tion by haptotaxis, by which cells move in response to differences in 
the concentration of substrate-bound signals. The ECM protein fi-
bronectin (FN) is abundant in tumor tissue, particularly around the 
vasculature and at the tumor periphery (Astrof et al., 2004; Zhou 
et al., 2008), and guides haptotaxis in breast cancer and melanoma 
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levels of MenaINV relative to the amounts found in invasive cells col-
lected from these tumors (Goswami et al., 2009; Oudin et al., 
2016a). We generated cell lines from the p53-mutant, triple-nega-
tive breast cancer cell line MDA-MB-231, which stably express Mena 
or MenaINV at levels similar to the amount of Mena found in invasive 
tumor cells (Wang et al., 2007; ∼10-fold overexpression with respect 
to endogenous Mena; cells referred to as 231-Control, 231-Mena, 
or 231-MenaINV). Previously we used a microfluidic device (Wu et al., 
2012) to study cells migrating on FN gradients by time-lapse imag-
ing, quantify the forward migration index (FMI), and assess their di-
rectional movement relative to the FN gradient (details in Supple-
mental Figure S1A). Given our recent findings that MenaINV enhances 
chemotactic response to EGF by dysregulating EGFR signaling, we 
wondered whether the EGFR signaling pathway might be involved 
in haptotaxis. Consistent with this possibility, erlotinib, an EGFR-
specific kinase inhibitor, blocked Mena-driven haptotaxis on low FN 
gradients (125 μg/ml FN at the top of the gradient; Figure 1, A and 
B), whereas 231-MenaINV cells required a 10-fold higher concentra-
tion of erlotinib than 231-Mena cells to block haptotaxis completely 
(Figure 1A). Of interest, the effects on haptotaxis were distinct from 
those on cell velocity: 0.1 μM erlotinib blocked Mena-driven hapto-
taxis without affecting velocity, whereas higher erlotinib concentra-
tions affected both haptotaxis and cell velocity (Figure 1B). We con-
firmed these findings using a second EGFR kinase inhibitor, gefitinib 
(Supplemental Figure S1B). To confirm the specificity of the inhibi-
tors, we used small interfering RNA (siRNA) to transiently knock 
down EGFR in the cell lines (Supplemental Figure S1C). Knockdown 
of EGFR inhibited Mena- and MenaINV-driven haptotaxis while sig-
nificantly decreasing cell velocity (Supplemental Figure S1, D and E). 
We previously found evidence that MenaINV expression enables 
haptotaxis at high FN concentrations (500 μg/ml FN at the top of 
the gradient; Oudin et al., 2016b). Here we found that erlotinib also 
inhibited MenaINV haptotaxis at high FN concentrations (Figure 1C). 
The overall velocity of all cells was reduced on high FN gradients, 
but again the effects on velocity versus directionality were distinct: 
0.1 μM erlotinib blocked MenaINV-driven haptotaxis without affect-
ing velocity (Figure 1D). We then investigated whether the hapto-
taxis-promoting EGFR activity on FN gradients required ligand-me-
diated receptor activation. Addition of mab225, which blocks 
EGF-dependent activation of EGFR but not its intrinsic kinase activ-
ity (Meyer et al., 2013), had no effect on haptotaxis or velocity 
(Figure 1, E and F), suggesting that the requirement for EGFR kinase 
activity revealed by sensitivity to erlotinib was not dependent on 
activation of EGFR by ligand. Together these data suggest that Me-
naINV-driven haptotaxis on low and high FN gradients requires EGFR 
signaling but not ligand-elicited EGFR activity.
MenaINV-driven haptokinesis requires EGFR signaling
Having shown that EGFR signaling is required for MenaINV-driven 
two-dimensional (2D) haptotaxis on FN gradients, we investigated 
whether this pathway was also important in haptokinesis—random 
migration induced by ECM cues. It is well known that FN can induce 
migration of cells; however, it does so in a biphasic manner, with 
highest levels of migration at intermediate concentrations (DiMilla 
et al., 1993). To investigate whether MenaINV plays a role in FN hap-
tokinesis, we examined cellular invasion in three-dimensional (3D) 
collagen gels containing uniform FN at different concentrations 
(Supplemental Figure S2A). We found that 231-Control and 231-
Mena cells exhibited a biphasic response to FN concentration, with 
maximum invasion elicited by 50 μg/ml FN and migration returning 
to baseline at 125 μg/ml (Supplemental Figure S2, B and C). In con-
trast, 231-MenaINV cells still invaded at maximal levels at the higher 
(Chan et al., 2014; Oudin et al., 2016b). The plethora of directional 
cues within the tumor microenvironment raises the question of how 
cells integrate their migration responses to these signals to metasta-
size efficiently.
Cells generally encounter multiple soluble and substrate-bound 
cues simultaneously in vivo. It is well established that the ECM binds 
growth factors (GFs), forming a GF reservoir that contributes to the 
generation of stable GF gradients (Hynes, 2009). Furthermore, ECM 
proteins themselves can activate receptor tyrosine kinases (RTKs), 
which occurs either via binding of intrinsic ECM domains such as 
EGF-like repeats to EGF receptor (EGFR) directly or via RTK transac-
tivation by integrins (Kuwada and Li, 2000; Balanis and Carlin, 2012). 
Finally, integrins and RTKs have been shown to signal together in 
the context of tumor cell invasion. The mutant version of the tumor 
suppressor p53, which is mutated in 50% of cancers, drives invasion 
through enhanced Rab coupling protein (RCP)–dependent recycling 
of α5β1, the main receptor for FN, and several RTKs, EGFR, and Met 
(Caswell et al., 2008; Muller et al., 2013). Although the potential for 
cross-talk between ECM and GF cues has been demonstrated, its 
role in haptotaxis and the relationship between chemotaxis and 
haptotaxis remains poorly understood.
The actin-regulatory protein Mena, a member of the Ena/VASP 
family of proteins, regulates cell migration and has been implicated 
in both chemotaxis and haptotaxis (Bear and Gertler, 2009; Gertler 
and Condeelis, 2011). Mena is up-regulated in breast cancer, and 
deletion of Mena in the PyMT-MMTV genetic model of breast can-
cer reduces metastasis (Roussos et al., 2010). During tumor progres-
sion, Mena is alternatively spliced to produce multiple functionally 
distinct isoforms. MenaINV, which contains a 19–amino acid inclu-
sion, is heterogeneously expressed in breast tumors and is associ-
ated with increased metastasis and poor clinical outcome, especially 
compared with expression of Mena alone (Oudin et al., 2016a,b). 
Mechanistically, MenaINV increases sensitivity to various GFs present 
within the tumor microenvironment, including EGF, hepatocyte 
growth factor (HGF), and insulin growth factor (IGF), by dysregulat-
ing the recruitment of the tyrosine phosphatase PTP1B to cognate 
receptors after ligand stimulation. Consequently expression of Me-
naINV causes increased receptor phosphorylation and corresponding 
cell invasion in response to low levels of ligand stimulation (Hughes 
et al., 2015). Second, Mena isoforms, and especially MenaINV, drive 
metastasis through their ability to support haptotaxis on FN gradi-
ents via direct α5 integrin interaction (Gupton et al., 2012; Oudin 
et al., 2016b). In particular, MenaINV allows cells to haptotax at high 
FN concentrations similar to those present around blood vessels 
and in the tumor periphery via increased outside-in signaling at fo-
cal complexes (FXs) and inside-out ECM remodeling (Oudin et al., 
2016b). Given its role in regulating responses to GFs and FN, we 
hypothesized that MenaINV could promote α5β1-EGFR cross-talk via 
receptor transactivation, recycling, or synergy. Here we demonstrate 
that MenaINV is a shared component of the machinery that mediates 
both haptotactic responses to FN and chemotactic responses to 
EGF.
RESULTS
Mena- and MenaINV-driven haptotaxis requires EGFR 
signaling
Given the established role of MenaINV in driving GF sensitization 
(Hughes et al., 2015) and promoting haptotaxis on FN gradients 
(Oudin et al., 2016b) and the emerging role of RTKs in response to 
ECM cues (Zhu and Clark, 2014), we asked whether MenaINV-driven 
haptotaxis on FN gradients requires EGFR signaling. Cultured 
breast tumor cells express low levels of Mena and undetectable 
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231-MenaINV ΔLERER cells did not display 
increased invasion in response to any of the 
FN concentrations tested (Supplemental 
Figure S2D). The apparent lack of invasion 
in the 50 μg/ml condition by 231-MenaINV 
ΔLERER cells suggests that this construct 
may have dominant-negative effects that 
block the modest proinvasive activity, for ex-
ample, by sequestering ligands bound to its 
other domains in the absence of the ability 
to interact with α5. Inhibition of α5β1 with 
blocking antibody P1D6 inhibited FN-driven 
invasion of 231-MenaINV cells (Supplemental 
Figure S2E). In contrast, Cilengitide-medi-
ated inhibition of αvβ3, another major FN 
receptor, had no effect (Supplemental 
Figure S2E). We then asked whether EGFR 
signaling was involved in MenaINV-driven in-
vasion into FN and found that erlotinib in-
hibited invasion of 231-MenaINV cells at all 
FN concentrations (Figure 2B). Together 
these data suggest that MenaINV-driven FN 
haptokinesis requires both α5β1 function 
and EGFR kinase activity.
MenaINV expression promotes EGFR 
signaling on FN
The requirement for EGFR signaling during 
haptotaxis prompted us to ask whether 
Mena and MenaINV drove EGFR phosphor-
ylation in cells migrating on FN gradients. 
In cells haptotaxing on FN gradients, we 
quantified levels of EGFR phosphorylation 
at Y1173, a residue exhibiting increased 
phosphorylation in 231-MenaINV after EGF 
stimulation (Hughes et al., 2015). First, we 
confirmed that expression of Mena, Mena-
INV, and variants with a deletion of the LE-
RER domain did not affect expression of 
EGFR (Supplemental Figure S3, A–C). Us-
ing immunofluorescence, we quantified 
pEGFRY1173 levels in cells plated on gradi-
ents of FN of different concentrations. On 
a low FN gradient, FN concentration cor-
related positively and significantly with 
pEGFRY1173 in 231-Mena and 231-MenaINV 
cells but not in control MDA-MB-231 cells 
(Figure 3, A–C). This correlation was absent 
when cells were treated with erlotinib (Sup-
plemental Figure S3, D–F). However, at 
high FN concentration, only 231-MenaINV cells showed a signifi-
cant correlation between pEGFRY1173 and FN (Figure 3, D–F). We 
then investigated whether Mena and MenaINV mRNA expression in 
human breast cancer patients was associated with phosphoryla-
tion of EGFR, using The Cancer Genome Atlas (TCGA) database 
(Cancer Genome Atlas Network, 2012). There was a significant 
correlation between levels of MenaINV, but not Mena, and levels of 
pY1068, but not pY1173, in human breast cancer patients from 
TCGA with available reverse-phase protein array data (Figure 3G). 
Of interest, in patients with high tumor FN mRNA levels, there was 
a weak but statistically significant correlation between MenaINV 
and pEGFRY1173 (Figure 3H). Together these data suggest that 
125 μg/ml FN concentration, indicating that 231-MenaINV cells have 
a shifted dose–response relation for FN (Figure 2A; see Supplemen-
tal Figure S2F for vehicle control). We then investigated the role of 
the interaction between MenaINV and the cytoplasmic tail of α5 inte-
grin in haptokinesis. The LERER region is unique to Mena and medi-
ates direct binding to the unique C-terminal portion of the cytoplas-
mic tail of α5 and not other α integrin subunits; deletion of LERER 
abrogates the interaction with α5 and has distinct functional 
consequences for adhesion signaling and migration (Gupton et al., 
2012; Oudin et al., 2016b). Similar to our previous observations 
for MenaINV-driven haptotaxis, we found that direct Mena–α5 integ-
rin interaction was required for MenaINV-driven haptokinesis, as 
FIGURE 1: Mena/MenaINV-driven FN haptotaxis requires EGFR. (A) Inhibition of EGFR with 
different concentrations of erlotinib decreased Mena- and MenaINV-driven haptotaxis on a 2D 
125 μg/ml low FN gradient, as measured by the FMI. (B) Velocity (μm/min) of 231, 231-Mena, 
and 231-MenaINV cells treated with increasing concentrations of erlotinib. (C) Inhibition of EGFR 
with different concentrations of erlotinib decreased MenaINV-driven haptotaxis on a 2D high 500 
μg/ml FN gradient. (D) Velocity (μm/min) of 231, 231-Mena, and 231-MenaINV cells treated with 
increasing concentrations of erlotinib on a high FN gradient. (E) FMI and (F) velocity of MDA-
MB-231, 231-Mena, and 231-MenaINV cells migrating on 2D low FN gradient with an 
immunoglobulin G control of mAB225. Data pooled from at least 50 cells from three different 
experiments. Results show mean ± SEM; significance by one-way ANOVA, *p < 0.05, **p < 0.01, 
***p < 0.005. Asterisks above a column in the graph characterize significance relative to control 
within that condition. See Supplemental Figure S1.
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necessary for this prohaptotactic effect because 231-MenaΔLERER 
and 231- MenaINVΔLERER cells did not haptotax in the presence of 
PTP1Bi (Figure 4C).
Because PTP1B is known to influence signaling at focal adhe-
sions (FXs; Burdisso et al., 2013), we hypothesized that the hapto-
tactic effect from PTP1Bi was associated with altered behavior of the 
key FX signaling regulator paxillin. We therefore performed immu-
nofluorescence studies on haptotaxing cells plated on a 2D FN gra-
dient for 3 h. We measured the number of pPAXY118-positive adhe-
sions in cells expressing different Mena isoforms plated on a 2D FN 
gradient. 231-MenaINV cells, which haptotax toward high FN con-
centrations, had a significantly increased number of pPAX-positive 
adhesions relative to 231-Control cells (Figure 4, D and E). To test 
whether the haptotaxis effect of PTP1Bi is due to changes in phos-
phorylation of proteins in adhesions, we measured the number of 
pPAXY118-positive adhesions in 231-Control treated with PTP1Bi and 
found an increase with drug treatment (Figure 4, D and E).
Given that PTP1Bi increases EGFR phosphorylation downstream 
of EGF stimulation (Hughes et al., 2015), we next investigated 
whether MenaINV could also promote FX signaling downstream of 
RTK activation. After EGF stimulation, 231-MenaINV cells show in-
creased FX-associated pPAXY118 compared with 231-Mena (Figure 
4F). In addition, PTP1Bi significantly increased pPAXY118 in 231-
Mena to similar levels as seen in 231-MenaINV (Figure 4F). Overall 
these data suggest that MenaINV drives PTP1B dysregulation and 
leads to increased FX signaling downstream of both chemotactic 
and haptotactic pathways.
Compared to Mena, MenaINV causes more sustained FX signal-
ing and enables haptotaxis at high FN concentrations (Oudin et al., 
2016b). Therefore we asked whether PTP1Bi could drive haptotaxis 
of MDA-MB-231 and 231-Mena cells on high FN gradients and 
found that PTP1Bi had no effect in this context (Figure 4G). This sug-
gests that the increase in FX signaling is not sufficient to support 
haptotaxis on high FN concentrations. Furthermore, we found that 
PTP1Bi failed to drive haptotaxis of MDA-MB-231 cells in three 
dimensions (Figure 4H). Taken together, these data confirm that 
MenaINV can regulate FX signaling downstream of multiple cues and 
suggest that there are additional functional requirements for 3D 
versus 2D haptotaxis.
Knockdown of p53 and RCP, known to drive cotrafficking 
and recycling of α5β1 and EGFR, inhibits MenaINV-driven 
haptotaxis and ECM reorganization
Whereas converging on signaling at adhesions is one way in which 
EGFR/α5β1 may contribute to motility, another way in which 
EGFR/α5β1 cross-talk could contribute to 3D invasion is via their 
dysregulated cotrafficking (Muller et al., 2011). Recycling of cotraf-
ficked α5β1/EGFR complexes is induced by expression of mutant 
p53 expression, which triggers RCP-mediated association between 
the two receptors, leading to increased invasion (Muller et al., 2009). 
Cells with mutant p53, such as the MDA-MB-231 cells used here, 
show increased levels of α5β1/EGFR recycling and preferential tar-
geting of the recycled complex to the pseudopods of invading cells 
in three dimensions. Of interest, by examining data from the TCGA 
breast cancer cohort, we found that breast cancer patients with mu-
tant p53 showed significantly higher levels of MenaINV than those 
with wild-type p53 (Figure 5A). Therefore we investigated whether 
dysregulated RCP-dependent recycling of α5β1/EGFR might also 
be involved in 3D haptotaxis by asking whether expression of either 
mutant p53 or RCP was required for MenaINV-driven 3D haptotaxis 
(Muller et al., 2009). First, we confirmed that there was no difference 
in level of total RCP or p53 expression in cells expressing Mena or 
high FN and MenaINV levels are correlated with increased EGFR 
activity.
Inhibition of PTP1B phenocopies MenaINV expression and 
drives haptotaxis
MenaINV expression affects sensitivity to proinvasion growth factors 
by dysregulating the phosphatase PTP1B; pharmacological inhibi-
tion of PTP1B (PTP1Bi) in parental MDA-MB-231 cells phenocopies 
many EGF-related MenaINV-driven phenotypes (Hughes et al., 2015). 
We therefore asked whether PTP1Bi could also drive haptotaxis of 
parental MDA-MB-231 in different contexts. PTP1Bi induced hapto-
taxis of MDA-MB-231 cells on a low 2D FN gradient without affect-
ing the migratory response of 231-Mena or 231-MenaINV cells 
(Figure 4A). We examined whether the PTPBi effects on signaling 
alone would support haptotaxis in the complete absence of even 
the low levels of endogenous Mena in parental MDA-MB-231 
cells. We found that clustered regularly interspaced short palin-
dromic repeats–mediated deletion of Mena (231-sgMena cells) 
indeed blocked this effect (Figure 4B; knockout validation in Sup-
plemental Figure S4A), suggesting that the prohaptotatic influ-
ence of PTP1Bi required endogenous Mena expression. Further-
more, the interaction between Mena/MenaINV and α5 was also 
FIGURE 2: EGFR signaling is important for MenaINV-driven FN 
haptokinesis. (A) In vitro invasion assay in a 3D collagen gel with 
increasing concentration of FN (0, 25, 50, 125, 175, 250 μg/ml) for 
231-MenaINV cells treated with serum-free medium for 24 h. The 
proportion of cells migrating 20 μm above baseline was quantified. 
(B) Treatment with erlotinib (0.1 or 1 μM) decreased the GF-
independent effect of FN on 3D invasion in 231-MenaINV cells. 
Mean ± SEM, results pooled from at least five different experiments; 
significance determined by one-way ANOVA, * p < 0.05, ** p < 0.01, 
*** p < 0.005. See Supplemental Figure S2.
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present simultaneously within the tumor microenvironment (Joyce 
and Pollard, 2009), we wondered how cells would respond to expo-
sure to both cues simultaneously. We first used an in vitro chemoin-
vasion assay (described in Supplemental Figure S1); in this instance, 
collagen plus FN gels were overlaid with varying EGF concentra-
tions. We verified the presence of gradients using fluorescent dex-
tran of similar molecular weight to EGF (Supplemental Figure S5). 
Addition of a low-dose EGF gradient (0.5 nM) in the presence of 25 
μg/ml FN/collagen did not affect the invasion of 231-Control or 231-
Mena cells; however, these conditions evoked a 3D invasion 
response by 231-MenaINV cells that was significantly greater than 
that observed for addition of either 0.5 nM or 25 μg/ml FN individu-
ally (p = 0.039, two-way analysis of variance [ANOVA] interaction 
term; Figure 6A). These data suggest that MenaINV promotes syn-
ergy between FN and EGF. We then investigated the role of the 
Mena–α5 interaction in this synergistic response. Of interest, dele-
tion of the LERER region in Mena or MenaINV did not affect protru-
sion of lamellipodia in response to low-dose EGF stimulation of cells 
MenaINV (or their corresponding LERER deletion mutants; Supple-
mental Figure S4, B–E). Knockdown of either p53 or RCP (Supple-
mental Figure S4, F–H), which was previously shown to block 3D 
invasion and recycling of α5β1/EGFR (Muller et al., 2009), decreased 
MenaINV-driven haptotaxis in three dimensions (Figure 5B). Three-
dimensional haptotaxis also requires ECM reorganization (Oudin 
et al., 2016b), reflected by increased accumulation of FN and colla-
gen around haptotaxis-competent cells in 3D gels. Knockdown of 
p53 and RCP led to a significant decrease in accumulation of FN 
and collagen around 231-MenaINV cells (Figure 5, C–E). Taken 
together, these data show a requirement for RCP and p53 in 
MenaINV-driven 3D haptotaxis and ECM reorganization, consistent 
with a model in which cotrafficking of α5β1/EGFR complexes sup-
ports these phenotypes.
MenaINV promotes synergy between EGF and FN
Our data suggest that MenaINV promotes directional migration 
downstream of α5β1 and RTKs. However, given that both cues are 
FIGURE 3: MenaINV drives EGFR signaling on FN. (A–C) Correlation between pEGFR1173 in whole cell relative to cell 
area and FN concentration under the cell in cells plated on a low 125 μg/ml FN gradient for MDA-MB-231 (A), 231-
Mena (B), and 231-MenaINV cells (C). (D–F) Correlation between pEGFR1173 in whole cell relative to cell area and FN 
concentration under the cell in cells plated on a low 125 μg/ml FN gradient for MDA-MB-231 (D), 231-Mena (E), and 
231-MenaINV cells (F). Data from at least 15 cells per cell line pooled from three different experiments. (G) Correlations 
(Spearman’s r and p value) between Mena or MenaINV and pEGFR1173 or pEGFR1068 from the reverse-phase protein 
assay (RPPA) data in the TCGA breast cancer cohort. (H) Correlations (Spearman’s r and p value) between Mena or 
MenaINV and pEGFR1173 or pEGFR1068 from the RPPA data in the TCGA breast cancer cohort in patients with high 
or low FN. See Supplemental Figure S3.
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into microneedles filled with growth factors 
and various ECM factors (Wyckoff et al., 
2000). We generated xenograft tumors by 
injecting MDA-MB-231 cells expressing 
Mena isoforms in the mammary fat pad of 
immune-compromised mice. The in vivo in-
vasion assay revealed that the combination 
of EGF and FN attracted more cells from 
231-MenaINV tumors than did each cue 
alone (Figure 6D). At the same concentra-
tions, the combination of EGF and FN did 
not have a synergistic effect on invasion in 
231-Control or 231-Mena tumors. Overall 
these data suggest that MenaINV promotes 
invasion by sensitizing cells to both soluble 
chemotactic signals and substrate-bound 
ECM signals and that MenaINV, via its α5 -in-
teraction, enables a superadditive com-
bined response.
DISCUSSION
Here we investigated EGFR and α5β1 sig-
naling cross-talk in the context of EGF che-
motaxis and FN haptotaxis. We found that 
the actin-binding protein MenaINV partici-
pates in ECM/GF cross-talk in three ways: 
FN-driven EGFR transactivation, synergistic 
activation downstream of EGFR and α5β1, 
and recycling of EGFR and α5β1. Taken to-
gether, these data suggest that MenaINV is a 
shared component of the EGF chemotaxis 
and FN haptotaxis responses, two distinct 
prometastatic pathways driving local inva-
sion in the tumor microenvironment.
First, our data point toward a role for 
MenaINV in promoting integrin and RTK 
signaling cross-talk downstream of both 
α5β1 and EGFR via receptor transactivation. 
MenaINV-driven 2D haptotaxis on FN 
requires EGFR activity driven by dysregu-
lated phosphatase PTP1B. Correspondingly, 
PTP1Bi drives 2D haptotaxis on FN gradi-
ents in a Mena-dependent manner. These 
data, combined with prior observation that 
MenaINV dysregulates PTP1B-dependent at-
tenuation of EGFR signaling, fit a model in 
which PTP1B facilitates α5β1/EGFR cross-
talk observed during 2D haptotaxis. PTP1B 
is known to be present at FXs and can be 
found in complexes of β1 and β3 integrin 
(Burdisso et al., 2013). Furthermore, PTP1B 
is required for integrin-dependent down-
regulation of RhoA and up-regulation of 
Rac1 (Burdisso et al., 2013). Therefore our data are consistent with 
PTP1B playing roles downstream of both RTKs and integrins. ECM/
GF cross-talk, such as ligand-independent activation of RTK signal-
ing, has been described in multiple contexts. For instance, FN-me-
diated activation of α5β1 leads to HGF-independent activation of 
Met to promote invasion (Mitra et al., 2011). Furthermore, α5β1-
dependent phosphorylation of platelet-derived growth factor-β 
(PDGFR-β) is induced upon cell adhesion to FN in the absence of 
any growth factor (Veevers-Lowe et al., 2011). Given that Met, 
plated on collagen and Matrigel, suggesting that acute actin polym-
erization in response to growth factor stimulation is intact in the ab-
sence of interaction with α5 (Supplemental Figure S6). However, in 
three dimensions in the presence of FN, the synergistic effect was 
eliminated by either abrogating the interaction between MenaINV 
and α5β1 (in 231-MenaINVΔLERER cells; Figure 6B) or inhibiting 
α5β1 with the P1D6 function blocking antibody (Figure 6C). To test 
this effect in vivo, we used an in vivo invasion assay, which allows for 
collection of cells from primary tumors by chemotaxis and invasion 
FIGURE 4: Inhibition of PTP1B phenocopies MenaINV. (A) FMI of MDA-MB-231, 231-Mena, and 
231-MenaINV cells treated with PT1Bi (10 μM) on a low 125 μg/ml FN gradient. (B) FMI of 
MDA-MB-231 cells with sgRNA targeted against a control sequence or Mena treated with PT1Bi 
(10 μM) on a low 125 μg/ml FN gradient. (C) FMI of 231-Mena ΔLERER and 231-MenaINVΔLERER 
cells treated with PT1Bi (10 μM) on a low 125 μg/ml FN gradient. (D) Representative images of 
231-Control cells showing GFP (green), F-actin (blue), and pPAX118 (red) for cells plated on a 
low 125 μg/ml FN gradient and treated with PT1Bi (10 μM). Scale bar, 5 μm (main image), 1 μm 
(inset). (E) Number of pPaxY118-positive adhesions in 231-Control and 231-MenaINV cells plated 
on a 2D FN gradient with DMSO or PTP1Bi treatment. (F) Levels of pPaxY118 in Mena- positive 
adhesions in 231-Mena and 231-MenaINV cells plated on collagen and Matrigel and treated with 
0.25 nM EGF for 1 min. (G) FMI of MDA-MB-231, 231-Mena, and 231-MenaINV cells treated with 
PT1Bi (10 μM) on a high 500 μg/ml FN gradient. (H) FMI of MDA-MB-231, 231-Mena, and 
231-MenaINV cells treated with PT1Bi (10 μM) in a 3D 125 μg/ml FN gradient. Haptotaxis data 
are pooled from at least three experiments, with at least 75 cells analyzed overall. Results show 
mean ± SEM; significance determined by one-way ANOVA, * p < 0.05, ** p < 0.01, *** 0.005. 
See Supplemental Figure S4.
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Second, we find that MenaINV promotes synergistic responses to 
combined EGF and FN gradients. Of interest, phospho–mass spec-
trometry analysis in 231-MenaINV cells treated with EGF revealed in-
creased phosphorylation of multiple proteins known to be present at 
FXs and playing a role in responses to ECM cues, such as vinculin, 
paxillin, P130Cas, and FAK (focal adhesion kinase) (Hughes et al., 
2015). Inhibition of PTP1B enables haptotaxis and increases FX sig-
naling downstream of both EGF and FN. It is well established that 
signaling downstream of RTKs and integrins can converge on com-
mon signaling pathways, such as the Ras–mitogen-activated protein 
kinase pathway, the phosphoinositide 3-kinase/Akt pathway, or Rho 
GTPases, particularly at focal adhesions (Huttenlocher and Horwitz, 
2011). However, how these pathways are coordinated to drive direc-
tional migration in response to multiple cues is poorly understood. 
Recent studies identified several important components of haptotac-
tic responses that are actually not required for GF chemotaxis, includ-
ing LKB1 signaling via kinases of the microtubule affinity-regulating 
kinase family (Chan et al., 2014). Of interest, two key cytoskeletal mol-
ecules—the Arp2/3 complex, which nucleates branched F-actin, and 
fascin, which supports filopodia formation through its F-actin bun-
dling activity—are also similarly required for haptotaxis on FN gradi-
ents (Wu et al., 2012; Johnson et al., 2015) but not for chemotaxis to 
growth factors. Therefore, whereas some signaling pathway compo-
nents are exclusively required downstream of a single directional cue, 
others, like MenaINV, may play roles in multiple modes of migration.
Finally, one other well-described mechanism by which RTK/inte-
grin cross-talk can promote invasion is through cotrafficking (Paul 
et al., 2015). Mutant p53 has been shown to drive p53-dependent 
recycling of α5β1 with EGFR and Met, a process that contributes to 
3D invasion (Muller et al., 2013). We previously reported that 
231-MenaINV cells show a 30% increase in surface α5 levels (Oudin 
et al., 2016b) and a small but significant 10% increase in EGFR recy-
cling (Hughes et al., 2015). Knockdown of p53 and RCP, which re-
duces the recycling of α5β1 and EGFR (Muller et al., 2009), also 
blocked MenaINV-driven 3D haptotaxis and ECM reorganization. 
Whether or not Mena isoforms directly contribute to receptor co-
trafficking is beyond the scope of the present study and will be the 
topic of future investigation.
Overall our study shed light on how cell migration behavior is 
coordinated by diverse and often overlapping signaling pathways 
that are activated during local tumor cell invasion, summarized in 
Figure 7. We focused on EGF and FN, both of which are present in 
the tumor microenvironment and can elicit directional tumor cell 
migration. However, given that there are many other cues present in 
the tumor microenvironment, it is likely that additional pathways 
participate in GF/ECM cross-talk downstream of a variety of cues 
and will contribute to metastasis.
MATERIALS AND METHODS
Antibody reagents, growth factors, and inhibitors
The growth factor EGF was from Life Technologies (Carlsbad, CA). 
Antibodies were as follows: EGFR (555996; BD Biosciences, 
San Jose, CA), paxillin (610052; BD Biosciences), pPaxillin Y118 
(44-722G; Life Technologies), and pEGFR1173 (Abcam, Cambridge, 
MA). Drugs were erlotinib (LC Labs, Woburn, MA), gefitinib (Pepro-
tech, Rocky Hill, NJ), Cilengitide (Selleck Chemicals, Houston, TX), 
P1D6 α5 blocking antibody (DSHB, Iowa City, IA), and PTP1Bi 
(Millipore, Burlington, MA).
Cell culture
MDA-MB-231 cells were obtained from the American Type Culture 
Collection (Manassas, VA) and cultured in DMEM with 10% serum 
PDGFR, and IGF1R are substrates for PTP1B and that MenaINV in-
creases sensitivity to HGF and IGF, it is possible that MenaINV-driven 
ECM/GF talk may extend to other RTKs. The data presented here 
point to MenaINV as a novel mediator of ECM-driven RTK transacti-
vation via PTP1B dysregulation.
FIGURE 5: Knockdown of RCP and p53 inhibits MenaINV-driven 
haptotaxis and ECM reorganization. (A) Reads per kilobase of 
transcript per million mapped reads for MenaINV in TCGA breast 
cancer patients with WT or mutant p53. (B) Knockdown of p53 and 
RCP (72 h) inhibits Mena- and MenaINV-driven 3D FN haptotaxis. 
(C) Representative images of 231-MenaINV cells (GFP) in a 3D 125 μg/
ml FN gradient (red) in a collagen gel (blue) with siCtrl, sip53, or 
siRCP. Scale bar, 25 μm. Knockdown of p53 and RCP (72 h) inhibited 
231-MenaINV–driven increased accumulation and reorganization of 
(D) FN and (E) collagen. Results show mean ± SEM; significance by 
one-way ANOVA, *p < 0.05, **p < 0.01, ***p < 0.005. See 
Supplemental Figure S4.
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captured over a 300-μm distance with 5-μm 
steps with a Nikon (Melville, NY) spinning-
disk confocal microscope using a 10×/0.75 
numerical aperture (NA) Phase Plan-Apo-
chromat objective, an Innova 70C Spec-
trum laser, and a Hamamatsu Orca ER cam-
era (Hamamatsu, Bridgewater, NJ). A 
custom-made Matlab (Natick, MA) pro-
gram was used to quantify the proportion 
of cells that migrated >20 μm (Miller et al., 
2013, 2015). Data were collected from at 
least three different experiments with at 
least three replicate wells in each experi-
ment. Synergy was calculated by two-way 
ANOVA.
Protrusion assay
Collagen-coated glass-bottomed dishes 
(MatTek, Ashland, MA) were coated with 
0.2% Matrigel in serum-free medium for 
30 min at 37°C. Cells were seeded sparsely 
overnight and then serum starved for 4 h 
in Leibowitz’s L-15 medium (Life Technolo-
gies) with 0.35% BSA. Differential interfer-
ence contrast images were acquired every 
20 s for 10 min in an environmentally con-
trolled microscope (TE2000; Nikon) with a 
20× objective and a Photometrics Cool-
SNAP HQ camera. Growth factor/inhibitor 
solutions were added after 80 s. Cell areas 
were traced immediately before and 9 min 
after stimulation using ImageJ (National 
Institutes of Health, Bethesda, MD). Data 
shown are from individual cells (at least 
60 overall) pooled from at least three sep-
arate experiments.
Western blot
Standard procedures were used for protein 
electrophoresis, Western blotting, and im-
munoprecipitation. MDA-MB-231 cells ex-
pressing different Mena isoforms were lysed in 25 mM Tris, 150 
mM NaCl, 10% glycerol, 1% NP-40, and 0.5 M EDTA with protease 
Mini-Complete protease inhibitors (Roche, Indianapolis, IN) and a 
phosphatase inhibitor cocktail (PhosSTOP; Roche) at 4°C. Protein 
lysates were separated by SDS–PAGE, transferred to a nitrocellu-
lose membrane, blocked with Odyssey Blocking Buffer (Li-Cor, Lin-
coln, NE), and incubated in primary antibody overnight at 4°C. 
Proteins were detected using Li-Cor secondary antibodies. Protein 
level intensity was measured with ImageJ, and data were pooled 
from at least three different experiments.
FACS
MDA-MB-231 cells expressing the different isoforms were trypsin-
ized, resuspended in medium, and then incubated with a primary 
antibody in phosphate-buffered saline (PBS) and 5% medium for 
30 min on ice. Next the cells were incubated with a species-appro-
priate, Alexa 647–tagged secondary antibody and then resus-
pended in PBS with 10 μg/ml propidium iodide. Samples were then 
analyzed on a FACSCalibur machine (BD Biosciences). Data were 
pooled from at least three separate experiments, with 10,000 cells 
analyzed per experiment.
and penicillin-streptomycin glutamine. Retroviral packaging, infec-
tion, and fluorescence-activated cell sorting (FACS) were performed 
as previously described (Gupton et al., 2012). Cell lines engineered 
to stably express Mena isoforms expressed 10- to 15-fold more 
protein than wild-type cell line (Oudin et al., 2016b). Knockdown of 
p53, RCP, and EGFR was performed using previously published 
siRNA sequences (obtained from Dharmacon, GE Lifesciences, 
Lafayette, CO; Muller et al., 2009) and transient transfection with 
Dharmafect4.
Three-dimensional in vitro chemotaxis assay 
We coated 96-well plates with 3% bovine serum albumin (BSA; 
Sigma, St. Louis, MO) at 37°C for 3 h. MDA-MB-231 cells express-
ing the different Mena isoforms were plated in 2 mg/ml collagen I 
(BD Biosciences) with 10× DMEM and 1 N NaOH and increasing 
concentrations of soluble bovine FN (Sigma) at 600,000 cells/ml 
on ice. Plates were then spun down at 1000 rpm for 8 min and 
placed in the incubator at 37°C for collagen to polymerize. After 1 
h, cells were treated with various growth factors. At 24 h later, gels 
were fixed with 4% paraformaldehyde and stained with the nuclear 
dye Yopro (Life Technologies). Images of the individual gels were 
FIGURE 6: MenaINV promotes synergy between FN and EGF. (A) In vitro chemotaxis assay in a 
3D collagen gel with EGF (0.5 nM), FN (25 μg/ml), or both for 231-Control, 231-Mena, and 
231-MenaINV cells. The proportion of cells migrating 20 μm above baseline is quantified. (B) 3D 
chemotaxis of 231-MenaINV and 231-MenaINVΔLERER cells with FN, EGF, or both. (C) Treatment 
with the α5-blocking antibody P1D6 blocked EGF/FN synergy in a 3D invasion assay. (D) In vivo 
invasion assay in tumors generated in NOD/SCID mice with MDA-MB-231 cells expressing 
Control-GFP, Mena, or MenaINV. Needles contain 1 mg/ml collagen and increasing amounts of 
FN or EGF (four mice per condition). Results show mean ± SEM; significance determined by one-
way ANOVA, * p < 0.05, ** p < 0.01, *** 0.005. See Supplemental Figures S5 and S6.
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cells are the same for Figures 1C and 4G, 
given that both erlotinib and PTP1Bi are in 
DMSO and experiments were carried out 
at once.
Immunofluorescence
Cells were plated in a haptotaxis device on a 
125 μg/ml 2D FN gradient for 3 h or on colla-
gen-coated glass-bottomed dishes (MatTek) 
in serum-free medium for 30 min at 37°C. 
Cells were then fixed for 20 min in 4% para-
formaldehyde in PHEM buffer (60 mM 
piperazine-N,N′-bis(ethanesulfonic acid), 
pH 7.0, 25 mM 4-(2-hydroxyethyl)-1-pipera-
zineethanesulfonic acid, pH 7.0, 10 mM eth-
ylene glycol tetraacetic acid, pH 8.0, 2 mM 
MgCl2, and 0.12 M sucrose) and then per-
meabilized with 0.2% Triton X-100, blocked 
with 10% BSA, and incubated with primary 
antibodies overnight at 37°C. Z-series of im-
ages were taken on an Applied Precision 
DeltaVision microscope using Softworx ac-
quisition, an Olympus 40×/1.3 NA Plan Apo 
objective, and a Photometrics CoolSNAP HQ camera. Images were 
deconvolved using DeltaVision Softworx software and objective-spe-
cific point spread function. Images were analyzed with ImageJ. Im-
ages are pooled from at least three independent experiments, with 
at least 10 cells per experiment.
TCGA data analysis
Data retrieval from TCGA was explained in Oudin et al. (2016b).
Tumor formation and in vivo invasion assay
MDA-MB-231 cells (2 million per mouse in PBS and 20% collagen 
I) expressing different Mena isoforms were injected into the fourth 
right mammary fat pad of 6-wk-old female NOD-SCID mice 
(Taconic, Hudson, NY). The in vivo invasion assay was performed in 
four mice per condition as previously described, once tumors had 
reached 1 cm in diameter, at ∼8 wk after injection (Wyckoff, 2004). 
Briefly, needles were held in place by a micromanipulator around a 
single mammary tumor of an anesthetized mouse. Needles con-
tained a mixture of 0.5 mg/ml collagen I, EDTA with L-15 medium, 
and 5 nM EGF and/or 50 μg/ml FN. After 4 h of cell collection, the 
contents of the needles were extruded. Cells were then stained 
with 4′,6-diamidino-2-phenylindole and counted.
Haptotaxis assay
Microfluidic devices were prepared as previously described (Wu 
et al., 2012). For 2D haptotaxis, after bonding polydimethylsilox-
ane devices to MatTek dishes, the cell culture chamber was coated 
with 0.1 mg/ml collagen I for 1 h at 37°C, and then 250 μg/ml fluo-
rescently labeled FN was flowed through the source channel for 1 
h. Cells were then plated in the device in full serum medium and 
left to attach for 1 h before imaging. For 3D haptotaxis, cells were 
resuspended in 1 mg/ml collagen I (BD Biosciences) with 10× 
DMEM, 1 N NaOH, and 3 nM EGF, plated in the cell culture cham-
ber, and left to settle for 8 h at 37°C. Fluorescently labeled FN (250 
μg/ml unless otherwise specified) was then flowed through the 
source channel for 1 h before imaging.
Cells were imaged overnight in the haptotaxis device, with im-
ages acquired every 10 min for 16 h in an environmentally con-
trolled microscope (TE2000, Nikon) with a 20× objective and a 
Photometrics CoolSNAP HQ camera. Individual cells were manu-
ally tracked using the ImageJ Manual Tracking plug-in. The tracks 
obtained were further analyzed using the chemotaxis tool 
developed by ibidi in ImageJ. This analysis tool was used to ex-
tract the FMI (Supplemental Figure S1A), which is defined as the 
displacement of the cell in the direction of the gradient divided 
by the total distance migrated; typical values for MDA-MB-231 
haptotaxis on FN gradients were in the range 0.1–0.25. Note that 
the dimethyl sulfoxide (DMSO) control data for the MDA-MB-231 
FIGURE 7: Model for MenaINV-driven cross-talk between EGFR and α5β1. MenaINV-driven 
chemotaxis requires the dysregulation of PTP1B, which leads to increased phosphorylation of 
both EGFR and paxillin located at FXs. MenaINV-driven haptotaxis requires EGFR-α5β1 cross-
talk: in two dimensions, via dysregulation of PTP1B signaling at FXs, and in three dimensions, via 
receptor recycling. As a result, tumor cells expressing MenaINV show increased invasion in 
response to both EGF and FN relative to each cue alone.
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